Treace Medical Concepts, Inc.
TMCI

$495.26 M
Marketcap
$7.95
Share price
Country
$-0.11
Change (1 day)
$15.98
Year High
$3.92
Year Low
Categories

Treace Medical Concepts, Inc., an orthopedic medical device company, engages in the design, manufacture, and marketing of medical devices for foot and ankle surgeons in the United States. It offers Lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with a cosmetic and medical improvement. The company also provides Lapiplasty Mini-Incision precision system. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, weil osteotomies, intercuneiform stabilization, lesser tarsometatarsal joint fusions, and autograft bone harvesting, as well as for MTP fusion. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.

marketcap

P/S ratio for Treace Medical Concepts, Inc. (TMCI)

P/S ratio as of 2023: 4.15

According to Treace Medical Concepts, Inc.'s latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.15. At the end of 2022 the company had a P/S ratio of 8.96.

P/S ratio history for Treace Medical Concepts, Inc. from 2019 to 2023

P/S ratio at the end of each year

Year P/S ratio
2023 4.15
2022 8.96
2021 10.70
2020 22.77
2019 33.14